MACROGENICS INC. - COMMON STOCK

MacroGenics Announces Date of First Quarter 2021 Financial Results Conference Call

19 أبريل 2021 16:30:00 بحسب Nasdaq GlobeNewswire

MacroGenics Announces Presentations at the 2021 AACR Annual Meeting

10 أبريل 2021 08:30:00 بحسب Nasdaq GlobeNewswire

MacroGenics to Participate in Upcoming Investor Conferences

26 فبراير 2021 07:30:00 بحسب Nasdaq GlobeNewswire

MacroGenics Provides Update on Corporate Progress and 2020 Financial Results

25 فبراير 2021 16:01:01 بحسب Nasdaq GlobeNewswire

MacroGenics Announces Date of Fourth Quarter and Full Year 2020 Financial Results Conference Call

18 فبراير 2021 16:30:00 بحسب Nasdaq GlobeNewswire

MacroGenics Names Federica O’Brien to its Board of Directors

11 فبراير 2021 16:30:00 بحسب Nasdaq GlobeNewswire

MacroGenics Announces Achievement of $10 Million Milestone Related to Retifanlimab Collaboration with Incyte

11 فبراير 2021 07:30:00 بحسب Nasdaq GlobeNewswire

MacroGenics to Participate in Upcoming Investor Conferences

08 فبراير 2021 07:30:00 بحسب Nasdaq GlobeNewswire

MacroGenics Announces Publication of SOPHIA Trial Results for MARGENZA™ in JAMA Oncology

25 يناير 2021 07:30:00 بحسب Nasdaq GlobeNewswire

MacroGenics to Participate in Upcoming Investor Conferences

11 يناير 2021 08:45:00 بحسب Nasdaq GlobeNewswire